Matches in Wikidata for { <http://www.wikidata.org/entity/Q66070648> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q66070648 description "assaig clínic" @default.
- Q66070648 description "clinical trial" @default.
- Q66070648 description "clinical trial" @default.
- Q66070648 description "clinical trial" @default.
- Q66070648 description "clinical trial" @default.
- Q66070648 description "ensaio clínico" @default.
- Q66070648 description "ensayo clínico" @default.
- Q66070648 description "ensayu clínicu" @default.
- Q66070648 description "essai clinique" @default.
- Q66070648 description "klinisch onderzoek" @default.
- Q66070648 description "клінічне випробування" @default.
- Q66070648 name "Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients" @default.
- Q66070648 name "Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients" @default.
- Q66070648 type Item @default.
- Q66070648 label "Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients" @default.
- Q66070648 label "Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients" @default.
- Q66070648 prefLabel "Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients" @default.
- Q66070648 prefLabel "Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients" @default.
- Q66070648 P1050 Q66070648-7695E080-CE6B-4738-B84B-CBD9BFC504F3 @default.
- Q66070648 P1132 Q66070648-D96826F7-63A8-47FC-8BDF-989A814E60DF @default.
- Q66070648 P1476 Q66070648-257EF053-4515-44F7-8D64-FA93D6E05BBA @default.
- Q66070648 P17 Q66070648-995B1C29-9B44-4211-B605-A674514CC8B6 @default.
- Q66070648 P1813 Q66070648-3E257D9E-824B-4CEC-A69C-6D963FD847F3 @default.
- Q66070648 P2899 Q66070648-61F6F6B3-FE68-4113-A655-08B0E4C82F56 @default.
- Q66070648 P3098 Q66070648-C361EB11-F138-430A-BE82-E6052031FFD2 @default.
- Q66070648 P31 Q66070648-19EAC1CB-026B-4BCD-92B1-F1F5A3EB4B41 @default.
- Q66070648 P4135 Q66070648-1670A29A-0184-4522-804A-31DB11EBE905 @default.
- Q66070648 P580 Q66070648-AE072385-8F53-4409-85EE-FD64882C29D0 @default.
- Q66070648 P582 Q66070648-CF8EF2BA-0199-4C2E-B8C3-36AA88BB9A26 @default.
- Q66070648 P6099 Q66070648-4269C1C3-D002-453D-AD82-D363CD8D0263 @default.
- Q66070648 P6099 Q66070648-EAE06B60-CAFA-4DE9-B81F-172E4A71956E @default.
- Q66070648 P6153 Q66070648-048403E8-B64C-4CFB-9E13-E7B44B43A0AA @default.
- Q66070648 P6153 Q66070648-EED1C3B3-649A-4A6F-9ADD-C70377C4C48E @default.
- Q66070648 P8363 Q66070648-C5F6A435-9A88-4BE8-9A1F-83455362A65C @default.
- Q66070648 P1050 Q1365309 @default.
- Q66070648 P1132 "+79" @default.
- Q66070648 P1476 "Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients" @default.
- Q66070648 P17 Q142 @default.
- Q66070648 P1813 "OLA-TMZ-RTE-01" @default.
- Q66070648 P2899 "+18" @default.
- Q66070648 P3098 "NCT03212742" @default.
- Q66070648 P31 Q30612 @default.
- Q66070648 P4135 "+70" @default.
- Q66070648 P580 "2017-09-04T00:00:00Z" @default.
- Q66070648 P582 "2022-01-31T00:00:00Z" @default.
- Q66070648 P6099 Q42824440 @default.
- Q66070648 P6099 Q5452194 @default.
- Q66070648 P6153 Q2451973 @default.
- Q66070648 P6153 Q3151727 @default.
- Q66070648 P8363 Q78089383 @default.